The MTT assay was employed to test cell viability. Following the manufacturer's protocol (Sigma-Aldrich), orbital fibroblasts isolated from GO patients and healthy non-GO donors were seeded into 24-well culture plates (1 × 105 cells/well) and treated with dimethylsulfoxide (DMSO; vehicle control) and different concentrations of CHIR 99021 (1, 5, 10, and 20 µM) for 18, 24, 48, and 72 hours. Thereafter, cells were washed and incubated in 5-mg/mL MTT solution for 3 hours at 37°C. Ice-cold isopropanol was applied for solubilization, and the absorbance of the converted dye was measured with a microplate reader (EL 340 Microplate Bio Kinetics Reader; Bio-Tek Instruments, Winooski, VT, USA) at 560 nm, with background subtraction at 630 nm.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.